Início › Câncer de Pâncreas › Utah › Salt Lake City
Ensaios clínicos de Câncer de Pâncreas em Salt Lake City, UT
15 estudos para Câncer de Pâncreas estão buscando participantes em locais em Salt Lake City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecrutandoFase 3
- University of Utah, Huntsman Cancer Institute, Salt Lake City
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecrutandoFase 3
- Investigative Site US053, Salt Lake City
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecrutandoFase 3
- Utah Cancer Specialists, Salt Lake City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecrutandoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecrutandoEstudo observacional
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Pancreatic Cancer Early Detection Consortium
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Huntsman Cancer Institute, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecrutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recrutando
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecrutandoFase 2
- Ohio State University-Telemedicine, Salt Lake City
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecrutandoFase 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
Ensaios de Câncer de Pâncreas em outras cidades
- Houston, TX61 estudos
- New York City, NY60 estudos
- Boston, MA43 estudos
- Nashville, TN39 estudos
- Los Angeles, CA35 estudos
- St. Louis, MO33 estudos
- Arlington, VA33 estudos
- Baltimore, MD31 estudos
- San Antonio, TX31 estudos
- Philadelphia, PA26 estudos
- Tampa, FL26 estudos
- Durham, NC24 estudos
Outros estudos em Salt Lake City
- Câncer de Pulmão de Não Pequenas Células31 estudos
- Câncer (todos os tipos)27 estudos
- Câncer de Mama27 estudos
- Câncer Colorretal22 estudos
- Câncer de Pulmão21 estudos
- Melanoma21 estudos
- Mieloma Múltiplo21 estudos
- Câncer Metastático20 estudos
- Câncer de Ovário19 estudos
- Obesidade18 estudos
- Leucemia Mieloide Aguda17 estudos
- Insuficiência Cardíaca17 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.